“…123 Many cases of depigmentation, some resembling vitiligo, have been reported following the use of the tyrosine kinase inhibitor imatinib, used in the treatment of chronic myeloid leukemia. 16,35,36 The successful use of autologous grafts to repigment the affected areas is not inconsistent with these theories. It appears to be required, in humans, for melanocyte proliferation.…”